SER Gregory Bailey buys $17K worth of shares
Sep 21, 2024, 12:32 AM
3.68%
What does SER do
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
Gregory Bailey bought 2,709 shares of SER on 18 September at $6.23 per share, worth a total of $17K. They now own 50,561 SER shares, or a 6% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.